Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines

Abstract

MAREK'S disease (MD) is a common neoplastic disease of the domestic fowl caused by a herpesvirus (MDV). It is controlled in the field by vaccination with artificially attenuated strains of MDV, or more commonly with the antigenically related herpesvirus of turkeys (HVT)1. The nature of the immune prophylaxis is not clear; protective immunity may be directed against MDV, against the development of tumours, or both. One way in which vaccination may exert its effect is by influencing the spread of MDV within the body2. In contrast, infected birds may occasionally recover after showing signs of MD clinically, and in some birds MD lymphoproliferative lesions regress3, so it is likely that there is also an anti-tumour immune reaction. We have sought evidence for anti-tumour immunity in experimentally immunised birds.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Biggs, P. M., Br. J. Cancer. 31, Suppl. II, 152–155 (1975).

    Google Scholar 

  2. Jackson, C. A. W., Biggs, P. M., Bell, R. A., Lancaster, R. M., and Milne, B. S., Avian Path., 3, 123–144 (1974).

    Article  CAS  Google Scholar 

  3. Sharma, J. M., Witter, R. L., and Burmester, B. R., Infect. Immun., 8, 715–724 (1973).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Powell, P. C., Payne, L. N., Frazier, J. A., and Rennie, M., Nature, 251, 79–80 (1974).

    Article  ADS  CAS  PubMed  Google Scholar 

  5. Witter, R. L., Stephens, E. A., Sharma, J. M., and Nazerian, K., J. Immun., 115, 177–183 (1975).

    CAS  PubMed  Google Scholar 

  6. Nazerian, K., and Lee, L. F., J. gen. Virol., 25, 317–321 (1974).

    Article  CAS  PubMed  Google Scholar 

  7. Avrameas, S., and Ternynck, T., Immunochemistry, 6, 53–66 (1969).

    Article  CAS  PubMed  Google Scholar 

  8. Sanderson, C. J., and Frost, P., Nature, 248, 690–691 (1974).

    Article  ADS  CAS  PubMed  Google Scholar 

  9. Payne, L. N., Frazier, J. A., and Powell, P. C., in International Review of Experimental Pathology (edit. by Richter, M., and Epstein, M. A.), 16 (Academic, New York, in the press).

  10. Kaaden, O. R., Dietzschold, B., and Ueberschär, S., Med. Microbiol. Immun., 159, 261–269 (1974).

    Article  CAS  Google Scholar 

  11. Lesnik, F., and Ross, L. J. N., Int. J. Cancer, 16, 153–163 (1975).

    Article  CAS  PubMed  Google Scholar 

  12. Powell, P. C., Payne, L. N., Frazier, J. A., and Rennie, M., in Proc. Second Int. Symp. Oncogenesis and Herpesviruses, Nuremberg, 1974 (International Agency for Research on Cancer, Lyon, in the press).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

POWELL, P. Immunity to Marek's disease induced by glutaraldehyde-treated cells of Marek's disease lymphoblastoid cell lines. Nature 257, 684–685 (1975). https://doi.org/10.1038/257684a0

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/257684a0

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing